ZIA CP010180 - 10675 (ZIA) | |||
---|---|---|---|
Title | AMH and prostate cancer risk in PLCO | ||
Institution | NCI, Bethesda, MD | ||
Principal Investigator | Cook, Michael | NCI Program Director | N/A |
Cancer Activity | N/A | Division | DCEG |
Funded Amount | $11,524 | Project Dates | 05/15/2013 - 00/00/0000 |
Fiscal Year | 2014 | Project Type | Intramural |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Biochemical Epidemiology (45.0%) Cancer (100.0%) |
Prostate (100.0%) | ||
Research Type | |||
Cancer-Related Biology Endogenous Factors in the Origin and Cause of Cancer |
|||
Abstract | |||
Prostate cancer biomarkers are in high demand as prostate cancer screening via PSA measurement demonstrates no improvement in prostate-cancer mortality and produces a high frequency of false positives. Despite the large body of evidence linking anti-m?llerian hormone (AMH) to cancer and the availability of a highly sensitive, reproducible assay, we have conducted the first epidemiological study of AMH in relation to prostate cancer risk in the PLCO (In Press). " |